Prevention of access-related infection in dialysis

References

• US Renal Data System: USRDS 2008 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. NIH, National Institue of Diabetes and Digestive and Kidney Diseases. Bethesda, MD, USA (2008).
   Google Scholar
• Johnson DW, McDonald SP, Excell L, Livingston B, Shtangey V. Peritoneal dialysis. In: ANZDATA Registry Report 2005 (Chapter 6). McDonal SP, Excell L (Eds). Adelaide, South Australia, 87–103 (2006).
   Google Scholar
• Ishani A, Collins AJ, Herzog CA, Foley RN. Septicemia, access and cardiovascular disease in dialysis patients: the USRDS Wave 2 study. Kidney Int.68(1), 311–318 (2005).
   PubMed Web of Science ®Google Scholar
• Roberts TL, Obrador GT, St Peter WL, Pereira BJ, Collins AJ. Relationship among catheter insertions, vascular access infections, and anemia management in hemodialysis patients. Kidney Int.66(6), 2429–2436 (2004).
   PubMedGoogle Scholar
• Zhang Y, Thamer M, Stefanik K, Kaufman J, Cotter DJ. Epoetin requirements predict mortality in hemodialysis patients. Am. J. Kidney Dis.44(5), 866–876 (2004).
   PubMed Web of Science ®Google Scholar
• Tordoir J, Canaud B, Haage P et al. EBPG on vascular access. Nephrol. Dial. Transplant.22(Suppl. 2), ii88–ii117 (2007).
   PubMed Web of Science ®Google Scholar
• Polkinghorne KR, McDonald SP, Atkins RC, Kerr PG. Vascular access and all-cause mortality: a propensity score analysis. J. Am. Soc. Nephrol.15(2), 477–486 (2004).
   PubMed Web of Science ®Google Scholar
• USRDS. Exerts from the USRDS 2002 annual data report: atlas of end-stage renal disease in the United States. Am. J. Kidney Dis.41, S1–S260 (2003).
   Google Scholar
• Pisoni RL. Vascular access use and outcomes: results from the DOPPS. Contrib. Nephrol.137, 13–19 (2002).
   Google Scholar
• Marr KA, Sexton DJ, Conlon PJ, Corey GR, Schwab SJ, Kirkland KB. Catheter-related bacteremia and outcome of attempted catheter salvage in patients undergoing hemodialysis. Ann. Intern. Med.127(4), 275–280 (1997).
   PubMed Web of Science ®Google Scholar
• Sesso R, Barbosa D, Leme IL et al.Staphylococcus aureus prophylaxis in hemodialysis patients using central venous catheter: effect of mupirocin ointment. J. Am. Soc. Nephrol.9(6), 1085–1092 (1998).
   PubMed Web of Science ®Google Scholar
• Johnson DW, MacGinley R, Kay TD et al. A randomized controlled trial of topical exit site mupirocin application in patients with tunnelled, cuffed haemodialysis catheters. Nephrol. Dial. Transplant.17(10), 1802–1807 (2002).
   PubMed Web of Science ®Google Scholar
• Johnson DW, van Eps C, Mudge DW et al. Randomized, controlled trial of topical exit-site application of honey (Medihoney) versus mupirocin for the prevention of catheter-associated infections in hemodialysis patients. J. Am. Soc. Nephrol.16(5), 1456–1462 (2005).
   PubMed Web of Science ®Google Scholar
• Beathard GA. Management of bacteremia associated with tunneled-cuffed hemodialysis catheters. J. Am. Soc. Nephrol.10(5), 1045–1049 (1999).
   PubMed Web of Science ®Google Scholar
• Kovalik EC, Raymond JR, Albers FJ et al. A clustering of epidural abscesses in chronic hemodialysis patients: risks of salvaging access catheters in cases of infection. J. Am. Soc. Nephrol.7(10), 2264–2267 (1996).
   PubMed Web of Science ®Google Scholar
• Taylor G, Gravel D, Johnston L, Embil J, Holton D, Paton S. Prospective surveillance for primary bloodstream infections occurring in Canadian hemodialysis units. Infect. Control Hosp. Epidemiol.23(12), 716–720 (2002).
   PubMed Web of Science ®Google Scholar
• Taylor G, Gravel D, Johnston L, Embil J, Holton D, Paton S. Incidence of bloodstream infection in multicenter inception cohorts of hemodialysis patients. Am. J. Infect. Control,32(3), 155–160 (2004).
   PubMed Web of Science ®Google Scholar
• Colville LA, Lee AH. Retrospective analysis of catheter-related infections in a hemodialysis unit. Infect. Control Hosp. Epidemiol.27(9), 969–973 (2006).
   PubMedGoogle Scholar
• Reed SD, Friedman JY, Engemann JJ et al. Costs and outcomes among hemodialysis-dependent patients with methicillin-resistant or methicillin-susceptible Staphylococcus aureus bacteremia. Infect. Control Hosp. Epidemiol.26(2), 175–183 (2005).
   PubMed Web of Science ®Google Scholar
• Inrig JK, Reed SD, Szczech LA et al. Relationship between clinical outcomes and vascular access type among hemodialysis patients with Staphylococcus aureus bacteremia. Clin. J. Am. Soc. Nephrol.1(3), 518–524 (2006).
   PubMedGoogle Scholar
• Taal MW, Fluck RJ, McIntyre CW. Preventing catheter related infections in haemodialysis patients. Curr. Opin. Nephrol. Hypertens.,15(6), 599–602 (2006).
   PubMedGoogle Scholar
• Winearls CG, Fluck R, Mitchell DC, Gibbons CP, Kessel D, Moss JG. The Organisation and Delivery of the Vascular Access Service for Maintenance Haemodialyisis Patients: Report of a Joint Working Party. Vascular Access Report. The Renal Association, Clinical Service Committee. 11 (2006).
   Google Scholar
• Jaffer Y, Selby NM, Taal MW, Fluck RJ, McIntyre CW. A meta-analysis of hemodialysis catheter locking solutions in the prevention of catheter-related infection. Am. J. Kidney Dis.51(2), 233–241 (2008).
   PubMed Web of Science ®Google Scholar
• Dhingra RK, Young EW, Hulbert-Shearon TE, Leavey SF, Port FK. Type of vascular access and mortality in U.S. hemodialysis patients. Kidney Int.60(4), 1443–1451 (2001).
   PubMed Web of Science ®Google Scholar
• Pastan S, Soucie JM, McClellan WM. Vascular access and increased risk of death among hemodialysis patients. Kidney Int.62(2), 620–626 (2002).
   PubMed Web of Science ®Google Scholar
• Strippoli GF, Tong A, Johnson D, Schena FP, Craig JC. Catheter type, placement and insertion techniques for preventing peritonitis in peritoneal dialysis patients. Cochrane Database Syst. Rev. (4), CD004680 (2004).
   Google Scholar
• Strippoli GF, Tong A, Johnson D, Schena FP, Craig JC. Antimicrobial agents for preventing peritonitis in peritoneal dialysis patients. Cochrane Database Syst. Rev. (4), CD004679 (2004).
   Google Scholar
• Wiggins KJ, Johnson DW, Craig JC, Strippoli GF. Treatment of peritoneal dialysis-associated peritonitis: a systematic review of randomized controlled trials. Am. J. Kidney Dis.50(6), 967–988 (2007).
   PubMed Web of Science ®Google Scholar
• Wiggins KJ, Craig JC, Johnson DW, Strippoli GF. Treatment for peritoneal dialysis-associated peritonitis. Cochrane Database Syst. Rev. (1), CD005284 (2008).
   Google Scholar
• Fried L, Abidi S, Bernardini J, Johnston JR, Piraino B. Hospitalization in peritoneal dialysis patients. Am. J. Kidney Dis.33(5), 927–933 (1999).
   PubMedGoogle Scholar
• Bernardini J, Bender F, Florio T et al. Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients. J. Am. Soc. Nephrol.16(2), 539–545 (2005).
   PubMedGoogle Scholar
• Piraino B, Bernardini J, Florio T, Fried L. Staphylococcus aureus prophylaxis and trends in Gram-negative infections in peritoneal dialysis patients. Perit. Dial. Int.23(5), 456–459 (2003).
   PubMed Web of Science ®Google Scholar
• Zimmerman SW, Ahrens E, Johnson CA et al. Randomized controlled trial of prophylactic rifampin for peritoneal dialysis-related infections. Am. J. Kidney Dis.18(2), 225–231 (1991).
   PubMedGoogle Scholar
• Johnson DW, McDonald SP, Excell L, Livingston B, Shtangey V. Peritoneal Dialysis. In: ANZDATA Registry Report 2006 (Chapter 6). McDonald SP, Excell L (Eds). Australia and New Zealand Dialysis and Transplant Registry, Adelaide, Australia, 87–103 (2007).
   Google Scholar
• Mujais S. Microbiology and outcomes of peritonitis in North America. Kidney Int.103, S55–S62 (2006).
   Google Scholar
• Aslam N, Bernardini J, Fried L, Burr R, Piraino B. Comparison of infectious complications between incident hemodialysis and peritoneal dialysis patients. Clin. J. Am. Soc. Nephrol.1(6), 1226–1233 (2006).
   PubMed Web of Science ®Google Scholar
• Johnson DW, Dent H, Hawley CM et al. Associations of dialysis modality and infectious mortality in incident dialysis patients in Australia and New Zealand. Am. J. Kidney Dis.53(2), 290–297 (2009).
   PubMedGoogle Scholar
• Allon M. Dialysis catheter-related bacteremia: treatment and prophylaxis. Am. J. Kidney Dis.44(5), 779–791 (2004).
   PubMed Web of Science ®Google Scholar
• Kim DK, Yoo TH, Ryu DR et al. Changes in causative organisms and their antimicrobial susceptibilities in CAPD peritonitis: a single center’s experience over one decade. Perit. Dial. Int.24(5), 424–432 (2004).
   PubMed Web of Science ®Google Scholar
• Kavanagh D, Prescott GJ, Mactier RA. Peritoneal dialysis-associated peritonitis in Scotland (1999–2002). Nephrol. Dial. Transplant.19(10), 2584–2591 (2004).
   PubMed Web of Science ®Google Scholar
• Miles R, Hawley CM, McDonald SP et al. Predictors and outcomes of fungal peritonitis in peritoneal dialysis patients. Kidney Int.76(6), 622–628 (2009).
   PubMedGoogle Scholar
• Santoianni JE, Predari SC, Veron D, Zucchini A, de Paulis AN. A 15 year-review of peritoneal dialysis-related peritonitis: microbiological trends and patterns of infection in a teaching hospital in Argentina. Rev. Argent. Microbiol.40(1), 17–23 (2008).
   PubMedGoogle Scholar
• Raad I, Costerton W, Sabharwal U, Sacilowski M, Anaissie E, Bodey GP. Ultrastructural analysis of indwelling vascular catheters: a quantitative relationship between luminal colonization and duration of placement. J. Infect. Dis.168(2), 400–407 (1993).
   PubMed Web of Science ®Google Scholar
• von Eiff C, Jansen B, Kohnen W, Becker K. Infections associated with medical devices: pathogenesis, management and prophylaxis. Drugs65(2), 179–214 (2005).
   PubMed Web of Science ®Google Scholar
• von Eiff C, Kohnen W, Becker K, Jansen B. Modern strategies in the prevention of implant-associated infections. Int. J. Artif. Organs28(11), 1146–1156 (2005).
   PubMed Web of Science ®Google Scholar
• McIntyre CW, Hulme LJ, Taal M, Fluck RJ. Locking of tunneled hemodialysis catheters with gentamicin and heparin. Kidney Int.66(2), 801–805 (2004).
   PubMed Web of Science ®Google Scholar
• Johnson DW, Pollock CA, Macdougall IC. Erythropoiesis-stimulating agent hyporesponsiveness. Nephrology (Carlton, Vic.)12(4), 321–330 (2007).
   PubMed Web of Science ®Google Scholar
• Dittmer ID, Sharp D, McNulty CA, Williams AJ, Banks RA. A prospective study of central venous hemodialysis catheter colonization and peripheral bacteremia. Clin. Nephrol.51(1), 34–39 (1999).
   PubMedGoogle Scholar
• Davies SJ, Ogg CS, Cameron JS, Poston S, Noble WC. Staphylococcus aureus nasal carriage, exit-site infection and catheter loss in patientstreated with continuous ambulatory peritoneal dialysis (CAPD). Perit. Dial. Int.9(1), 61–64 (1989).
   PubMedGoogle Scholar
• Dasgupta MK, Kowalewaska-Grochowska K, Costerton JW. Biofilm and peritonitis in peritoneal dialysis. Perit. Dial. Int.13(Suppl. 2), S322–S325 (1993).
   PubMedGoogle Scholar
• Finkelstein ES, Jekel J, Troidle L, Gorban-Brennan N, Finkelstein FO, Bia FJ. Patterns of infection in patients maintained on long-term peritoneal dialysis therapy with multiple episodes of peritonitis. Am. J. Kidney Dis.39(6), 1278–1286 (2002).
   PubMed Web of Science ®Google Scholar
• Anwar H, Dasgupta MK, Costerton JW. Testing the susceptibility of bacteria in biofilms to antibacterial agents. Antimicrob. Agents Chemother.34(11), 2043–2046 (1990).
   PubMed Web of Science ®Google Scholar
• Brulez HF, Verbrugh HA. First-line defense mechanisms in the peritoneal cavity during peritoneal dialysis. Perit. Dial. Int.15(7 Suppl.), S24–S33 (1995).
   Google Scholar
• Jorres A, Gahl GM, Frei U. In vitro studies on the effect of dialysis solutions on peritoneal leukocytes. Perit. Dial. Int.15(Suppl. 7), S41–S45 (1995).
   PubMed Web of Science ®Google Scholar
• Pajek J, Kveder R, Bren A et al. Short-term effects of a new bicarbonate/lactate-buffered and conventional peritoneal dialysis fluid on peritoneal and systemic inflammation in CAPD patients: a randomized controlled study. Perit. Dial. Int.28(1), 44–52 (2008).
   PubMedGoogle Scholar
• Furkert J, Zeier M, Schwenger V. Effects of peritoneal dialysis solutions low in GDPs on peritonitis and exit-site infection rates. Perit. Dial. Int.28(6), 637–640 (2008).
   PubMedGoogle Scholar
• Lee HY, Park HC, Seo BJ et al. Superior patient survival for continuous ambulatory peritoneal dialysis patients treated with a peritoneal dialysis fluid with neutral pH and low glucose degradation product concentration (Balance). Perit. Dial. Int.25(3), 248–255 (2005).
   PubMed Web of Science ®Google Scholar
• Sherertz RJ, Ely EW, Westbrook DM et al. Education of physicians-in-training can decrease the risk for vascular catheter infection. Ann. Intern. Med.132(8), 641–648 (2000).
   PubMed Web of Science ®Google Scholar
• Sanders RA, Sheldon GF. Septic complications of total parenteral nutrition. A five year experience. Am. J. Surg.,132(2), 214–220 (1976).
   PubMedGoogle Scholar
• Ryan JA Jr, Abel RM, Abbott WM et al. Catheter complications in total parenteral nutrition. A prospective study of 200 consecutive patients. N. Engl. J. Med.290(14), 757–761 (1974).
   PubMed Web of Science ®Google Scholar
• Murphy LM, Lipman TO. Central venous catheter care in parenteral nutrition: a review. JPEN J. Parenter. Enteral. Nutr.11(2), 190–201 (1987).
   PubMedGoogle Scholar
• Eggimann P, Harbarth S, Constantin MN, Touveneau S, Chevrolet JC, Pittet D. Impact of a prevention strategy targeted at vascular-access care on incidence of infections acquired in intensive care. Lancet355(9218), 1864–1868 (2000).
   PubMed Web of Science ®Google Scholar
• Keohane PP, Jones BJ, Attrill H et al. Effect of catheter tunnelling and a nutrition nurse on catheter sepsis during parenteral nutrition. A controlled trial. Lancet2(8364), 1388–1390 (1983).
   PubMed Web of Science ®Google Scholar
• Beathard GA. Catheter management protocol for catheter-related bacteremia prophylaxis. Semin Dial,16(5), 403–405 (2003).
   PubMedGoogle Scholar
• NKF-K/DOQI Clinical Practise Guidelines for Vascular Access, Update 2006, Guideline 15: catheter care and accessing the patients circulation. Am. J. Kidney Dis.37(Suppl. 1), S157–S159 (2001).
   PubMedGoogle Scholar
• Maki DG, Band JD. A comparative study of polyantibiotic and iodophor ointments in prevention of vascular catheter-related infection. Am. J. Med.70(3), 739–744 (1981).
   PubMed Web of Science ®Google Scholar
• Levin A, Mason AJ, Jindal KK, Fong IW, Goldstein MB. Prevention of hemodialysis subclavian vein catheter infections by topical povidone-iodine. Kidney Int.40(5), 934–938 (1991).
   PubMed Web of Science ®Google Scholar
• Maki DG, Ringer M, Alvarado CJ. Prospective randomised trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet338(8763), 339–343 (1991).
   PubMed Web of Science ®Google Scholar
• Humar A, Ostromecki A, Direnfeld J et al. Prospective randomized trial of 10% povidone-iodine versus 0.5% tincture of chlorhexidine as cutaneous antisepsis for prevention of central venous catheter infection. Clin. Infect. Dis.31(4), 1001–1007 (2000).
   PubMed Web of Science ®Google Scholar
• Tattawasart U, Maillard JY, Furr JR, Russell AD. Development of resistance to chlorhexidine diacetate and cetylpyridinium chloride in Pseudomonas stutzeri and changes in antibiotic susceptibility. J. Hosp. Infect.42(3), 219–229 (1999).
   PubMedGoogle Scholar
• Schwab SJ, Weiss MA, Rushton F et al. Multicenter clinical trial results with the LifeSite hemodialysis access system. Kidney Int.62(3), 1026–1033 (2002).
   PubMedGoogle Scholar
• Quarello F, Forneris G. Prevention of hemodialysis catheter-related bloodstream infection using an antimicrobial lock. Blood Purif.20(1), 87–92 (2002).
   PubMed Web of Science ®Google Scholar
• Yu VL, Goetz A, Wagener M et al.Staphylococcus aureus nasal carriage and infection in patients on hemodialysis. Efficacy of antibiotic prophylaxis. N. Engl. J. Med.315(2), 91–96 (1986).
   PubMed Web of Science ®Google Scholar
• Bommer J, Vergetis W, Andrassy K, Hingst V, Borneff M, Huber W. Elimination of Staphylococcus aureus in hemodialysis patients. ASAIO J.41(1), 127–131 (1995).
   PubMedGoogle Scholar
• Boelaert JR, Van Landuyt HW, Godard CA et al. Nasal mupirocin ointment decreases the incidence of Staphylococcus aureus bacteraemias in haemodialysis patients. Nephrol. Dial. Transplant.8(3), 235–239 (1993).
   PubMed Web of Science ®Google Scholar
• Cavdar C, Atay T, Zeybel M et al. Emergence of resistance in staphylococci after long-term mupirocin application in patients on continuous ambulatory peritoneal dialysis. Adv. Perit. Dial.20, 67–70 (2004).
   PubMedGoogle Scholar
• Lobbedez T, Gardam M, Dedier H et al. Routine use of mupirocin at the peritoneal catheter exit site and mupirocin resistance: still low after 7 years. Nephrol. Dial. Transplant.19(12), 3140–3143 (2004).
   PubMed Web of Science ®Google Scholar
• Deshpande LM, Fix AM, Pfaller MA, Jones RN. Emerging elevated mupirocin resistance rates among staphylococcal isolates in the SENTRY Antimicrobial Surveillance Program (2000): correlations of results from disk diffusion, Etest and reference dilution methods. Diagn. Microbiol. Infect. Dis.42(4), 283–290 (2002).
   PubMed Web of Science ®Google Scholar
• James MT, Conley J, Tonelli M, Manns BJ, MacRae J, Hemmelgarn BR. Meta-analysis: antibiotics for prophylaxis against hemodialysis catheter-related infections. Ann. Intern. Med.148(8), 596–605 (2008).
   PubMed Web of Science ®Google Scholar
• Lok CE, Stanley KE, Hux JE, Richardson R, Tobe SW, Conly J. Hemodialysis infection prevention with polysporin ointment. J. Am. Soc. Nephrol.14(1), 169–179 (2003).
   PubMed Web of Science ®Google Scholar
• Miles R, Johnson D. Use of honey to prevent infections associated with medical devices. In: Honey: A Modern Wound Management Product. Cooper R, Molan P, White R (Eds). Wounds UK Books, Dorset, UK, 91–105 (2008).
   Google Scholar
• Cooper RA, Halas E, Molan PC. The efficacy of honey in inhibiting strains of Pseudomonas aeruginosa from infected burns. J. Burn Care Rehabil.23(6), 366–370 (2002).
   PubMedGoogle Scholar
• Cooper RA, Molan PC, Harding KG. The sensitivity to honey of Gram-positive cocci of clinical significance isolated from wounds. J. Appl. Microbiol.93(5), 857–863 (2002).
   PubMed Web of Science ®Google Scholar
• Namias N. Honey in the management of infections. Surg. Infect. (Larchmt)4(2), 219–226 (2003).
   PubMedGoogle Scholar
• Subrahmanyam M. Early tangential excision and skin grafting of moderate burns is superior to honey dressing: a prospective randomised trial. Burns25(8), 729–731 (1999).
   PubMed Web of Science ®Google Scholar
• Molan PC. Potential of honey in the treatment of wounds and burns. Am. J. Clin. Dermatol.2(1), 13–19 (2001).
   PubMedGoogle Scholar
• Moore OA, Smith LA, Campbell F, Seers K, McQuay HJ, Moore RA. Systematic review of the use of honey as a wound dressing. BMC Complement. Altern. Med.1, 2 (2001).
   PubMedGoogle Scholar
• Dixon B. Bacteria can’t resist honey. Lancet Infect. Dis.3(2), 116 (2003).
   PubMed Web of Science ®Google Scholar
• Yahav D, Rozen-Zvi B, Gafter-Gvili A, Leibovici L, Gafter U, Paul M. Antimicrobial lock solutions for the prevention of infections associated with intravascular catheters in patients undergoing hemodialysis: systematic review and meta-analysis of randomized, controlled trials. Clin. Infect. Dis.,47(1), 83–93 (2008).
   PubMed Web of Science ®Google Scholar
• Bleyer AJ. Use of antimicrobial catheter lock solutions to prevent catheter-related bacteremia. Clin. J. Am. Soc. Nephrol.2(5), 1073–1078 (2007).
   PubMed Web of Science ®Google Scholar
• Nori US, Manoharan A, Yee J, Besarab A. Comparison of low-dose gentamicin with minocycline as catheter lock solutions in the prevention of catheter-related bacteremia. Am. J. Kidney Dis.48(4), 596–605 (2006).
   PubMed Web of Science ®Google Scholar
• Dogra GK, Herson H, Hutchison B et al. Prevention of tunneled hemodialysis catheter-related infections using catheter-restricted filling with gentamicin and citrate: a randomized controlled study. J. Am. Soc. Nephrol.13(8), 2133–2139 (2002).
   PubMed Web of Science ®Google Scholar
• Kim SH, Song KI, Chang JW et al. Prevention of uncuffed hemodialysis catheter-related bacteremia using an antibiotic lock technique: a prospective, randomized clinical trial. Kidney Int.69(1), 161–164 (2006).
   PubMed Web of Science ®Google Scholar
• Saxena AK, Panhotra BR, Sundaram DS et al. Tunneled catheters’ outcome optimization among diabetics on dialysis through antibiotic-lock placement. Kidney Int.70(9), 1629–1635 (2006).
   PubMed Web of Science ®Google Scholar
• Sayearr N, Maki DG. Use of vancomycin-containing lock or flush solutions for prevention of bloodstream infection associated with central venous access devices: a meta-analysis of prospective, randomized trials. Clin. Infect. Dis.43(4), 474–484 (2006).
   PubMedGoogle Scholar
• Weijmer MC, van den Dorpel MA, Van de Ven PJ et al. Randomized, clinical trial comparison of trisodium citrate 30% and heparin as catheter-locking solution in hemodialysis patients. J. Am. Soc. Nephrol.16(9), 2769–2777 (2005).
   PubMed Web of Science ®Google Scholar
• Duncan N, Singh S, Amao Mea. A single centre randomised controlled trial of sodium citrate versus heparin line locks for cuffed central venous catheters (abstract). J. Am. Soc. Nephrol.16, 451A (2005).
   Google Scholar
• Power A, Duncan N, Singh SK et al. Sodium citrate versus heparin catheter locks for cuffed central venous catheters: a single-center randomized controlled trial. Am. J. Kidney Dis.53(6), 1034–1041 (2009).
   PubMed Web of Science ®Google Scholar
• Traub WH, Leonhard B, Bauer D. Taurolidine: In vitro activity against multiple antibiotic resistant nosocomially significant clinical isolates of Staphylococcus aureus, Enterococcus faecium, and diverse Enterobacteriaceae. Chemotherapy39, 322–330 (1993).
   PubMedGoogle Scholar
• Mermel LA, Parenteau S. Efficacy of the Biolink Catheter Lock Solution (CLS) for DIALOCK Hemodialysis Access Port and Catheters – an in-vitro model. On Site Program. International Conference on Nosocomial and Healthcare-Associated Infections. Sponsored by CDC, sdrg (2000).
   Google Scholar
• Betjes MG, van Agteren M. Prevention of dialysis catheter-related sepsis with a citrate-taurolidine-containing lock solution. Nephrol. Dial. Transplant.19(6), 1546–1551 (2004).
   PubMed Web of Science ®Google Scholar
• Metcalf SC, Chambers ST, Pithie AD. Use of ethanol locks to prevent recurrent central line sepsis. J. Infect.49(1), 20–22 (2004).
   PubMed Web of Science ®Google Scholar
• Maharaj AR, Zelenitsky SA, Vercaigne LM. Effect of an ethanol/trisodium citrate hemodialysis catheter locking solution on isolates of Candida albicans. Hemodial. Int.12(3), 342–347 (2008).
   PubMedGoogle Scholar
• Takla TA, Zelenitsky SA, Vercaigne LM. Effect of ethanol/trisodium citrate lock on microorganisms causing hemodialysis catheter-related infections. J. Vasc. Access8(4), 262–267 (2007).
   PubMedGoogle Scholar
• Takla TA, Zelenitsky SA, Vercaigne LM. Effectiveness of a 30% ethanol/4% trisodium citrate locking solution in preventing biofilm formation by organisms causing haemodialysis catheter-related infections. J. Antimicrob. Chemother.62(5), 1024–1026 (2008).
   PubMedGoogle Scholar
• Ackoundou-N’guessan C, Heng AE, Guenu S et al. Ethanol lock solution as an adjunct treatment for preventing recurrent catheter-related sepsis – first case report in dialysis setting. Nephrol. Dial. Transplant.21(11), 3339–3340 (2006).
   PubMedGoogle Scholar
• Dannenberg C, Bierbach U, Rothe A, Beer J, Korholz D. Ethanol-lock technique in the treatment of bloodstream infections in pediatric oncology patients with broviac catheter. J. Pediatr. Hematol. Oncol.25(8), 616–621 (2003).
   PubMed Web of Science ®Google Scholar
• Onland W, Shin CE, Fustar S, Rushing T, Wong WY. Ethanol-lock technique for persistent bacteremia of long-term intravascular devices in pediatric patients. Arch. Pediatr. Adolesc. Med.160(10), 1049–1053 (2006).
   PubMedGoogle Scholar
• Raad I, Hanna H, Maki D. Intravascular catheter-related infections: advances in diagnosis, prevention, and management. Lancet Infect. Dis.7(10), 645–657 (2007).
   PubMed Web of Science ®Google Scholar
• Haxhe JJ, D’Hoore W. A meta-analysis dealing with the effectiveness of chlorhexidine and silver-sufhadiazine impregnated central venous catheters. J. Hosp. Infect.40(2), 166–168 (1998).
   PubMedGoogle Scholar
• Dahlberg PJ, Agger WA, Singer JR et al. Subclavian hemodialysis catheter infections: a prospective, randomized trial of an attachable silver-impregnated cuff for prevention of catheter-related infections. Infect. Control Hosp. Epidemiol.16(9), 506–511 (1995).
   PubMed Web of Science ®Google Scholar
• European Best Practise Guidelines for Haemodialysis (Part 1). Haemodialysis-associated infection. Nephrol. Dial. Transplant.17(Suppl. 7), 1–111 (2002).
   Google Scholar
• European Best Practise Guidelines for Haemodialysis (Part 2). Haemodialysis-associated infection. Nephrol. Dial. Transplant.22(Suppl. 2), ii1–ii118 (2007).
   PubMedGoogle Scholar
• Wikdahl AM, Engman U, Stegmayr BG, Sorenssen JG. One-dose cefuroxime i.v. and i.p. reduces microbial growth in PD patients after catheter insertion. Nephrol. Dial. Transplant.12(1), 157–160 (1997).
   PubMed Web of Science ®Google Scholar
• Bennet-Jones DN, Martin JB, Barratt AJ, Duffy TJ, Naish PF, Aber GM. Prophylactic gentamicin in the prevention of early exit-site infectons and peritonitis in CAPD. Adv. Perit. Dial.4, 147–150 (1988).
   Google Scholar
• Gadallah MF, Ramdeen G, Mignone J, Patel D, Mitchell L, Tatro S. Role of preoperative antibiotic prophylaxis in preventing postoperative peritonitis in newly placed peritoneal dialysis catheters. Am. J. Kidney Dis.36(5), 1014–1019 (2000).
   PubMed Web of Science ®Google Scholar
• Lye WC, Lee EJ, Tan CC. Prophylactic antibiotics in the insertion of Tenckhoff catheters. Scand. J. Urol. Nephrol.26(2), 177–180 (1992).
   PubMed Web of Science ®Google Scholar
• Piraino B, Bailie GR, Bernardini J et al. Peritoneal dialysis-related infections recommendations: 2005 update. Perit. Dial. Int.25(2), 107–131 (2005).
   PubMed Web of Science ®Google Scholar
• European Best Practice Guidelines for Peritoneal Dialysis. Peritoneal access. Nephrol. Dial. Transplant.20(Suppl. 9), ix8–ix12 (2005).
   PubMedGoogle Scholar
• Gadallah MF, Pervez A, el-Shahawy MA et al. Peritoneoscopic versus surgical placement of peritoneal dialysis catheters: a prospective randomized study on outcome. Am. J. Kidney Dis.33(1), 118–122 (1999).
   PubMed Web of Science ®Google Scholar
• Tsimoyiannis EC, Siakas P, Glantzounis G et al. Laparoscopic placement of the Tenckhoff catheter for peritoneal dialysis. Surg. Laparosc. Endosc. Percutan. Tech.10(4), 218–221 (2000).
   PubMed Web of Science ®Google Scholar
• Wright MJ, Bel’eed K, Johnson BF, Eadington DW, Sellars L, Farr MJ. Randomized prospective comparison of laparoscopic and open peritoneal dialysis catheter insertion. Perit. Dial. Int.19(4), 372–375 (1999).
   PubMed Web of Science ®Google Scholar
• Jwo SC, Chen KS, Lee CC, Chen HY. Prospective randomized study for comparison of open surgery with laparoscopic-assisted placement of Tenckhoff peritoneal dialysis catheter – a single center experience and literature review. J. Surg. Res. (2008) (Epub ahead of print).
   PubMedGoogle Scholar
• Strippoli GF, Tong A, Johnson D, Schena FP, Craig JC. Catheter-related interventions to prevent peritonitis in peritoneal dialysis: a systematic review of randomized, controlled trials. J. Am. Soc. Nephrol.15(10), 2735–2746 (2004).
   PubMedGoogle Scholar
• Ejlersen E, Steven K, Lokkegaard H. Paramedian versus midline incision for the insertion of permanent peritoneal dialysis catheters. A randomized clinical trial. Scand. J. Urol. Nephrol.24(2), 151–154 (1990).
   PubMed Web of Science ®Google Scholar
• Rubin J, Didlake R, Raju S, Hsu H. A prospective randomized evaluation of chronic peritoneal catheters. Insertion site and intraperitoneal segment. ASAIO Trans.36(3), M497–M500 (1990).
   Google Scholar
• Moncrief JW, Popovich RP, Dasgupta M, Costerton JW, Simmons E, Moncrief B. Reduction in peritonitis incidence in continuous ambulatory peritoneal dialysis with a new catheter and implantation technique. Perit. Dial. Int.13(Suppl. 2), S329–S331 (1993).
   Google Scholar
• Park MS, Yim AS, Chung SH et al. Effect of prolonged subcutaneous implantation of peritoneal catheter on peritonitis rate during CAPD: a prospective randomized study. Blood Purif.16(3), 171–178 (1998).
   PubMedGoogle Scholar
• Danielsson A, Blohme L, Tranaeus A, Hylander B. A prospective randomized study of the effect of a subcutaneously ‘buried’ peritoneal dialysis catheter technique versus standard technique on the incidence of peritonitis and exit-site infection. Perit. Dial. Int.22(2), 211–219 (2002).
   PubMedGoogle Scholar
• Moncrief JW, Popovich R. Subcutaneous buried versus standard peritoneal dialysis catheter. Presented at: XVIII Annual CAPD Conference. Nashville, TN, USA, 24 February 1998.
   Google Scholar
• Dasgupta MK, Perri D, Fox S. Exit-site infection, but not peritonitis, is reduced by the use of Moncrief–Popovich catheters in comparison to Tenckhoff catheters. Presented at: American Society of Nephrology Renal Week. Toronto, Canada, 13 October 2000.
   Google Scholar
• Twardowski ZJ, Prowant BF, Pickett B, Nichols WK, Nolph KD, Khanna R. Four-year experience with swan neck presternal peritoneal dialysis catheter. Am. J. Kidney Dis.27(1), 99–105 (1996).
   PubMedGoogle Scholar
• Twardowski ZJ. Presternal peritoneal catheter. Adv. Ren. Replace. Ther.9(2), 125–132 (2002).
   PubMedGoogle Scholar
• Akyol AM, Porteous C, Brown MW. A comparison of two types of catheters for continuous ambulatory peritoneal dialysis (CAPD). Perit. Dial. Int.10(1), 63–66 (1990).
   PubMedGoogle Scholar
• Eklund BH, Honkanen EO, Kala AR, Kyllonen LE. Catheter configuration and outcome in patients on continuous ambulatory peritoneal dialysis: a prospective comparison of two catheters. Perit. Dial. Int.14(1), 70–74 (1994).
   PubMedGoogle Scholar
• Eklund BH, Honkanen EO, Kala AR, Kyllonen LE. Peritoneal dialysis access: prospective randomized comparison of the Swan neck and Tenckhoff catheters. Perit. Dial. Int.15(8), 353–356 (1995).
   PubMedGoogle Scholar
• Lye WC, Kour NW, van der Straaten JC, Leong SO, Lee EJ. A prospective randomized comparison of the swan neck, coiled, and straight Tenckhoff catheters in patients on CAPD. Perit. Dial. Int.16(Suppl. 1), S333–S335 (1996).
   PubMedGoogle Scholar
• Nielsen PK, Hemmingsen C, Friis SU, Ladefoged J, Olgaard K. Comparison of straight and curled Tenckhoff peritoneal dialysis catheters implanted by percutaneous technique: a prospective randomized study. Perit. Dial. Int.15(1), 18–21 (1995).
   PubMedGoogle Scholar
• Scott PD, Bakran A, Pearson R et al. Peritoneal dialysis access. Prospective randomized trial of 3 different peritoneal catheters – preliminary report. Perit. Dial. Int.14(3), 289–290 (1994).
   PubMedGoogle Scholar
• Johnson DW, Wong J, Wiggins KJ et al. A randomized controlled trial of coiled versus straight swan-neck Tenckhoff catheters in peritoneal dialysis patients. Am. J. Kidney Dis.48(5), 812–821 (2006).
   PubMedGoogle Scholar
• US Renal Data System Annual Data Report IV. Catheter-related factors and peritonitis risk in CAPD patients. Am. J. Kidney Dis.20(Suppl. 2), 48–54 (1992).
   PubMedGoogle Scholar
• Honda M, Iitaka K, Kawaguchi H et al. The Japanese National Registry data on pediatric CAPD patients: a ten-year experience. A report of the Study Group of Pediatric PD Conference. Perit. Dial. Int.16(3), 269–275 (1996).
   PubMed Web of Science ®Google Scholar
• Warady BA, Sullivan EK, Alexander SR. Lessons from the peritoneal dialysis patient database: a report of the North American Pediatric Renal Transplant Cooperative Study. Kidney Int.53, S68–S71 (1996).
   Google Scholar
• Eklund B, Honkanen E, Kyllonen L, Salmella K, Kala AR. Peritoneal dialysis access: prospective randomized comparison of single-cuff and double-cuff straight Tenckhoff catheters. Nephrol. Dial. Transplant.12(12), 2664–2666 (1997).
   PubMedGoogle Scholar
• Miller TE, Findon G. Touch contamination of connection devices in peritoneal dialysis – a quantitative microbiologic analysis. Perit. Dial. Int.17(6), 560–567 (1997).
   PubMedGoogle Scholar
• Dryden MS, Ludlam HA, Wing AJ, Phillips I. Active intervention dramatically reduces CAPD-associated infection. Adv. Perit. Dial.7, 125–128 (1991).
   PubMedGoogle Scholar
• Hall G, Bogan A, Dreis S et al. New directions in peritoneal dialysis patient training. Nephrol. Nurs. J.31(2), 149–154, 159–163 (2004).
   PubMedGoogle Scholar
• Luzar MA, Brown CB, Balf D et al. Exit-site care and exit-site infection in continuous ambulatory peritoneal dialysis (CAPD): results of a randomized multicenter trial. Perit. Dial. Int.10(1), 25–29 (1990).
   PubMedGoogle Scholar
• Burkart JM, Hylander B, Durnell-Figel T, Roberts D. Comparison of peritonitis rates during long-term use of standard spike versus Ultraset in continuous ambulatory peritoneal dialysis (CAPD). Perit. Dial. Int.10(1), 41–43 (1990).
   PubMedGoogle Scholar
• Maiorca R, Cantaluppi A, Cancarini GC et al. Prospective controlled trial of a Y-connector and disinfectant to prevent peritonitis in continuous ambulatory peritoneal dialysis. Lancet2(8351), 642–644 (1983).
   PubMedGoogle Scholar
• Scalamogna A, De Vecchi A, Castelnovo C, Guerra L, Ponticelli C. Long-term incidence of peritonitis in CAPD patients treated by the Y set technique: experience in a single center. Nephron55(1), 24–27 (1990).
   PubMedGoogle Scholar
• Harris DC, Yuill EJ, Byth K, Chapman JR, Hunt C. Twin- versus single-bag disconnect systems: infection rates and cost of continuous ambulatory peritoneal dialysis. J. Am. Soc. Nephrol.7(11), 2392–2398 (1996).
   PubMedGoogle Scholar
• Kiernan L, Kliger A, Gorban-Brennan N et al. Comparison of continuous ambulatory peritoneal dialysis-related infections with different ‘Y-tubing’ exchange systems. J. Am. Soc. Nephrol.5(10), 1835–1838 (1995).
   PubMedGoogle Scholar
• Li PK, Szeto CC, Law MC et al. Comparison of double-bag and Y-set disconnect systems in continuous ambulatory peritoneal dialysis: a randomized prospective multicenter study. Am. J. Kidney Dis.33(3), 535–540 (1999).
   PubMedGoogle Scholar
• Monteon F, Correa-Rotter R, Paniagua R et al. Prevention of peritonitis with disconnect systems in CAPD: a randomized controlled trial. The Mexican Nephrology Collaborative Study Group. Kidney Int.54(6), 2123–2128 (1998).
   PubMedGoogle Scholar
• Cheng IK, Chan CY, Cheng SW et al. A randomized prospective study of the cost-effectiveness of the conventional spike, O-set, and UVXD techniques in continuous ambulatory peritoneal dialysis. Perit. Dial. Int.14(3), 255–260 (1994).
   PubMedGoogle Scholar
• Peritonitis in continuous ambulatory peritoneal dialysis (CAPD): a multi-centre randomized clinical trial comparing the Y connector disinfectant system to standard systems. Canadian CAPD Clinical Trials Group. Perit. Dial. Int.9(3), 159–163 (1989).
   PubMedGoogle Scholar
• Dryden MS, McCann M, Wing AJ, Phillips I. Controlled trial of a Y-set dialysis delivery system to prevent peritonitis in patients receiving continuous ambulatory peritoneal dialysis. J. Hosp. Infect.20(3), 185–192 (1992).
   PubMedGoogle Scholar
• Li PK, Chan TH, So WY, Wang AY, Leung CB, Lai KN. Comparisons of Y-set disconnect system (Ultraset) versus conventional spike system in uremic patients on CAPD: outcome and cost analysis. Perit. Dial. Int.16(Suppl. 1), S368–S370 (1996).
   Google Scholar
• Owen JE, Walker RG, Lemon J, Brett L, Mitrou D, Becker GJ. Randomized study of peritonitis with conventional versus O-set techniques in continuous ambulatory peritoneal dialysis. Perit. Dial. Int.12(2), 216–220 (1992).
   PubMedGoogle Scholar
• Viglino G, Colombo A, Scalamogna A et al. Prospected randomized study of two Y devices in continuous ambulatory peritoneal dialysis (CAPD). Perit. Dial. Int.9(3), 165–168 (1989).
   PubMedGoogle Scholar
• Viglino G, Colombo A, Cantu P et al.In vitro and in vivo efficacy of a new connector device for continuous ambulatory peritoneal dialysis. Perit. Dial. Int.13(Suppl. 2), S148–S151 (1993).
   Google Scholar
• Rottembourg J, Brouard R, Issad B, Allouache M, Jacobs C. Prospective randomized study about Y connectors in CAPD patients. Adv. Perit. Dial.3, 107–113 (1987).
   Google Scholar
• Lindholm T, Simonsen O, Krutzen L. Evaluation of a new take-off system (Ultraset) versus conventional spike system in uremic patients on CAPD: outcome and cost-analysis. Adv. Perit. Dial.4, 262–265 (1988).
   Google Scholar
• Daly CD, Campbell MK, MacLeod AM et al. Do the Y-set and double-bag systems reduce the incidence of CAPD peritonitis? A systematic review of randomized controlled trials. Nephrol. Dial. Transplant.16(2), 341–347 (2001).
   PubMed Web of Science ®Google Scholar
• Luzar MA, Coles GA, Faller B et al.Staphylococcus aureus nasal carriage and infection in patients on continuous ambulatory peritoneal dialysis. N. Engl. J. Med.322(8), 505–509 (1990).
   PubMed Web of Science ®Google Scholar
• Nouwen J, Schouten J, Schneebergen P et al.Staphylococcus aureus carriage patterns and the risk of infections associated with continuous peritoneal dialysis. J. Clin. Microbiol.,44(6), 2233–2236 (2006).
   PubMed Web of Science ®Google Scholar
• No authors listed. Nasal mupirocin prevents Staphylococcus aureus exit-site infection during peritoneal dialysis. Mupirocin Study Group. J. Am. Soc. Nephrol.7(11), 2403–2408 (1996).
   PubMedGoogle Scholar
• Annigeri R, Conly J, Vas S et al. Emergence of mupirocin-resistant Staphylococcus aureus in chronic peritoneal dialysis patients using mupirocin prophylaxis to prevent exit-site infection. Perit. Dial. Int.21(6), 554–559 (2001).
   PubMed Web of Science ®Google Scholar
• Perez-Fontan M, Rosales M, Rodriguez-Carmona A, Falcon TG, Valdes F. Mupirocin resistance after long-term use for Staphylococcus aureus colonization in patients undergoing chronic peritoneal dialysis. Am. J. Kidney Dis.39(2), 337–341 (2002).
   PubMed Web of Science ®Google Scholar
• Conly JM, Vas S. Increasing mupirocin resistance of Staphylococcus aureus in CAPD – should it continue to be used as prophylaxis? Perit. Dial. Int.22(6), 649–652 (2002).
   PubMedGoogle Scholar
• Thodis E, Bhaskaran S, Pasadakis P, Bargman JM, Vas SI, Oreopoulos DG. Decrease in Staphylococcus aureus exit-site infections and peritonitis in CAPD patients by local application of mupirocin ointment at the catheter exit site. Perit. Dial. Int.18(3), 261–270 (1998).
   PubMed Web of Science ®Google Scholar
• Thodis E, Passadakis P, Panagoutsos S, Bacharaki D, Euthimiadou A, Vargemezis V. The effectiveness of mupirocin preventing Staphylococcus aureus in catheter-related infections in peritoneal dialysis. Adv. Perit. Dial.16, 257–261 (2000).
   PubMedGoogle Scholar
• Casey M, Taylor J, Clinard P et al. Application of mupirocin cream at the catheter exit site reduces exit-site infections and peritonitis in peritoneal dialysis patients. Perit. Dial. Int.20(5), 566–568 (2000).
   PubMedGoogle Scholar
• Bernardini J, Piraino B, Holley J, Johnston JR, Lutes R. A randomized trial of Staphylococcus aureus prophylaxis in peritoneal dialysis patients: mupirocin calcium ointment 2% applied to the exit site versus cyclic oral rifampin. Am. J. Kidney Dis.27(5), 695–700 (1996).
   PubMed Web of Science ®Google Scholar
• Xu Y, Dong J, Zuo L. Is frequency of patient-physician clinic contact important in peritoneal dialysis patients? Perit. Dial. Int.29(Suppl. 2), S83–S89 (2009).
   Google Scholar
• Chu KH, Choy WY, Cheung CC et al. A prospective study of the efficacy of local application of gentamicin versus mupirocin in the prevention of peritoneal dialysis catheter-related infections. Perit. Dial. Int.28(5), 505–508 (2008).
   PubMedGoogle Scholar
• Johnson DW, Clark C, Isbel NM et al. The Honeypot Study Protocol: a randomized controlled trial of exit-site application of medihoney antibacterial wound gel for the prevention of catheter-associated infections in peritoneal dialysis patients. Perit. Dial. Int.29(3), 303–309 (2009).
   PubMedGoogle Scholar
• Montenegro J, Saracho R, Aguirre R, Martinez I, Iribar I, Ocharan J. Exit-site care with ciprofloxacin otologic solution prevents polyurethane catheter infection in peritoneal dialysis patients. Perit. Dial. Int.20(2), 209–214 (2000).
   PubMedGoogle Scholar
• Jassal SV, Lok CE. A randomized controlled trial comparing mupirocin versus polysporin triple for the prevention of catheter-related infections in peritoneal dialysis patients (the MP3 study). Perit. Dial. Int.28(1), 67–72 (2008).
   PubMedGoogle Scholar
• Blowey DL, Warady BA, McFarland KS. The treatment of Staphylococcus aureus nasal carriage in pediatric peritoneal dialysis patients. Adv. Perit. Dial.10, 297–299 (1994).
   PubMedGoogle Scholar
• Falagas ME, Fragoulis KN, Bliziotis IA. Oral rifampin for prevention of S. aureus carriage-related infections in patients with renal failure – a meta-analysis of randomized controlled trials. Nephrol. Dial. Transplant.21(9), 2536–2542 (2006).
   PubMedGoogle Scholar
• Churchill DN, Taylor DW, Vas SI. Peritonitis in continuous ambulatory peritoneal dialysis patients: a randomized clinical trial of cotrimoxazole prophylaxis. Perit. Dial. Int.8, 125–128 (1988).
   Google Scholar
• Low DE, Vas SI, Oreopoulos DG et al. Prophylactic cephalexin ineffective in chronic ambulatory peritoneal dialysis. Lancet2(8197), 753–754 (1980).
   PubMedGoogle Scholar
• Sesso R, Parisio K, Dalboni A et al. Effect of sodium fusidate and ofloxacin on Staphylococcus aureus colonization and infection in patients on continuous ambulatory peritoneal dialysis. Clin. Nephrol.41(6), 370–376 (1994).
   PubMedGoogle Scholar
• Troidle L, Kliger AS, Goldie SJ et al. Continuous peritoneal dialysis-associated peritonitis of nosocomial origin. Perit. Dial. Int.16(5), 505–510 (1996).
   PubMed Web of Science ®Google Scholar
• Fried LF, Bernardini J, Johnston JR, Piraino B. Peritonitis influences mortality in peritoneal dialysis patients. J. Am. Soc. Nephrol.7(10), 2176–2182 (1996).
   PubMed Web of Science ®Google Scholar
• Zaruba K, Peters J, Jungbluth H. Successful prophylaxis for fungal peritonitis in patients on continuous ambulatory peritoneal dialysis: six years’ experience. Am. J. Kidney Dis.17(1), 43–46 (1991).
   PubMedGoogle Scholar
• Moreiras-Plaza M, Vello-Roman A, Samprom-Rodriguez M, Feijoo-Pineiro D. Ten years without fungal peritonitis: a single center’s experience. Perit. Dial. Int.27(4), 460–463 (2007).
   PubMed Web of Science ®Google Scholar
• Wong PN, Lo KY, Tong GM et al. Prevention of fungal peritonitis with nystatin prophylaxis in patients receiving CAPD. Perit. Dial. Int.27(5), 531–536 (2007).
   PubMed Web of Science ®Google Scholar
• Robitaille P, Merouani A, Clermont MJ, Hebert E. Successful antifungal prophylaxis in chronic peritoneal dialysis: a pediatric experience. Perit. Dial. Int.15(1), 77–79 (1995).
   PubMed Web of Science ®Google Scholar
• Williams PF, Moncrieff N, Marriott J. No benefit in using nystatin prophylaxis against fungal peritonitis in peritoneal dialysis patients. Perit. Dial. Int.20(3), 352–353 (2000).
   PubMed Web of Science ®Google Scholar
• Thodis E, Vas SI, Bargman JM, Singhal M, Chu M, Oreopoulos DG. Nystatin prophylaxis: its inability to prevent fungal peritonitis in patients on continuous ambulatory peritoneal dialysis. Perit. Dial. Int.18(6), 583–589 (1998).
   PubMed Web of Science ®Google Scholar
• Lo WK, Chan CY, Cheng SW, Poon JF, Chan DT, Cheng IK. A prospective randomized control study of oral nystatin prophylaxis for Candida peritonitis complicating continuous ambulatory peritoneal dialysis. Am. J. Kidney Dis.28(4), 549–552 (1996).
   PubMed Web of Science ®Google Scholar
• Strippoli GF, Tong A, Johnson D, Schena FP, Craig JC. Antimicrobial agents to prevent peritonitis in peritoneal dialysis: a systematic review of randomized controlled trials. Am. J. Kidney Dis.44(4), 591–603 (2004).
   PubMedGoogle Scholar
• Poole-Warren LA, Hallett MD, Hone PW, Burden SH, Farrell PC. Vaccination for prevention of CAPD associated staphylococcal infection: results of a prospective multicentre clinical trial. Clin. Nephrol.35(5), 198–206 (1991).
   PubMed Web of Science ®Google Scholar
• Nolphe KD, Prowant B, Serkes K et al.A randomized multicentre clinical trial to evaluate the effects of an ultravioulet germicidal system on peritonitis rate in continuous ambulatory peritoneal dialysis. Periton. Dial. Bull.1, 19–24 (1985).
   Google Scholar